Prevalence and severity of cerebral amyloid angiopathy: a population-based study on very elderly Finns (Vantaa 85+)

被引:30
作者
Tanskanen, M. [1 ]
Makela, M. [1 ]
Myllykangas, L. [1 ,2 ]
Notkola, I. -L. [3 ]
Polvikoski, T. [6 ]
Sulkava, R. [4 ,5 ]
Kalimo, H. [1 ]
Paetau, A. [1 ]
机构
[1] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki 00014, Finland
[2] Biomedicum Helsinki, Folkhalsan Inst Genet, Helsinki, Finland
[3] Finnish Informat Ctr Register Res, Helsinki, Finland
[4] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland
[5] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland
[6] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
cerebral amyloid angiopathy; population-based study; prevalence; severity; ALZHEIMERS-DISEASE; TOPOGRAPHICAL DISTRIBUTION; DEMENTIA; BRAIN;
D O I
10.1111/j.1365-2990.2011.01219.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
M. Tanskanen, M. Makela, L. Myllykangas, I.-L. Notkola, T. Polvikoski, R. Sulkava, H. Kalimo and A. Paetau (2012) Neuropathology and Applied Neurobiology38, 329336 Prevalence and severity of cerebral amyloid angiopathy: a population-based study on very elderly Finns (Vantaa 85+) Background: Cerebral amyloid angiopathy (CAA) is frequent in patients with Alzheimer's disease while its prevalence in different populations is variable. We investigated the prevalence and severity of CAA in a very elderly Finnish population. Methods: Neuropathological investigation was performed on 306 subjects from the population-based Vantaa 85+ Study (253 women, 53 men, mean age at death 92.3 years). The presence of CAA was analysed in six brain regions by using Congo red and immunohistochemistry with an antibody against amyloid beta peptide. The severity of CAA was assessed by counting the percentage of the CAA-positive blood vessels. Results: In total, 69.6% of the participants (170 women, 43 men) had CAA, with median severity of 1.0%, inter-quartile range (IQR) 05.4% and range 072.7%. CAA was more prevalent (81.1% vs. 67.2%; P = 0.046) and severe (median 2.7%, IQR 0.47.5%, range 072.7%) in the men than in the women (median 1.0%, IQR 04.6%, range 052.8%; P = 0.004). Parietal lobe showed the highest prevalence (57.8%) whereas the severity was highest (median 1.0%, IQR 06.0%, range 077%) in the frontal lobe. Prevalence of CAA in the six regions was variable, but the severity indices between those regions correlated highly (P < 0.001 for all regions). Meningeal CAA was more prevalent (69.5%) than cortical (59.3%; P < 0.001). Conclusion: CAA was highly prevalent, albeit mild, in the very old. The prevalence and severity of CAA were found to be highest in the frontal and parietal lobes respectively independent of the staining method used (Congo red or amyloid beta peptide).
引用
收藏
页码:329 / 336
页数:8
相关论文
共 28 条
[1]   Cerebral Amyloid Angiopathy Pathology and Cognitive Domains in Older Persons [J].
Arvanitakis, Zoe ;
Leurgans, Sue E. ;
Wang, Zhenxin ;
Wilson, Robert S. ;
Bennett, David A. ;
Schneider, Julie A. .
ANNALS OF NEUROLOGY, 2011, 69 (02) :320-327
[2]   Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy [J].
Attems, J ;
Jellinger, KA ;
Lintner, F .
ACTA NEUROPATHOLOGICA, 2005, 110 (03) :222-231
[3]   Sporadic cerebral amyloid angiopathy [J].
Attems, J. ;
Jellinger, K. ;
Thal, D. R. ;
Van Nostrand, W. .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2011, 37 (01) :75-93
[4]   Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology [J].
Attems, Johannes ;
Quass, Magdalena ;
Jellinger, Kurt A. ;
Lintner, Felix .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 257 (1-2) :49-55
[5]   Consequence of A immunization on the vasculature of human Alzheimers disease brain [J].
Boche, D. ;
Zotova, E. ;
Weller, R. O. ;
Love, S. ;
Neal, J. W. ;
Pickering, R. M. ;
Wilkinson, D. ;
Holmes, C. ;
Nicoll, J. A. R. .
BRAIN, 2008, 131 :3299-3310
[6]   Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study [J].
Brayne, Carol ;
Richardson, Kathryn ;
Matthews, Fiona E. ;
Fleming, Jane ;
Hunter, Sally ;
Xuereb, John H. ;
Paykel, Eugene ;
Mukaetova-Ladinska, Elizabeta B. ;
Huppert, Felicia A. ;
O'Sullivan, Angela ;
Dening, Tom .
JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (03) :645-658
[7]   Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience .15. [J].
Ellis, RJ ;
Olichney, JM ;
Thal, LJ ;
Mirra, SS ;
Morris, JC ;
Beekly, D ;
Heyman, A .
NEUROLOGY, 1996, 46 (06) :1592-1596
[8]   CEREBRAL AMYLOID ANGIOPATHY IN DEMENTIA AND OLD-AGE [J].
ESIRI, MM ;
WILCOCK, GK .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (11) :1221-1226
[9]  
Esiri MM, 2001, LANCET, V357, P169
[10]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890